公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1997 | Effects of depolarization and NMDA antagonists on the survival of cerebellar granule cells: A pivotal role for protein kinase C isoforms | WAN-WAN LIN | Journal of Neurochemistry | | | |
1995 | Effects of protein kinase A activation on endothelin- and ATP-induced signal transduction | WAN-WAN LIN | European Journal of Pharmacology - Molecular Pharmacology Section | | | |
1993 | Endothelin- and ATP-induced inhibition of adenylyl cyclase activity in C6 glioma cells: Role of Gi and calcium | WAN-WAN LIN | Molecular Pharmacology | | | |
1991 | Endothelin- and sarafotoxin-induced phosphoinositide hydrolysis in cultured cerebellar granule cells: Biochemical and pharmacological characterization | WAN-WAN LIN | Journal of Pharmacology and Experimental Therapeutics | | | |
1991 | Endothelin-induced activation of phosphoinositide turnover, calcium mobilization, and transmitter release in cultured neurons and neurally related cell types | WAN-WAN LIN | Journal of Cardiovascular Pharmacology | | | |
2015 | Global Oct4 target gene analysis reveals novel downstream PTEN and TNC genes required for drug-resistance and metastasis in lung cancer | Tang, Yen-An; CHI-HSIN SALLY CHEN ; Sun, H Sunny; Cheng, Chun-Pei; Tseng, Vincent S; Hsu, Han-Shui; Su, Wu-Chou; WAN-WAN LIN; Wang, Yi-Ching | Nucleic acids research | 49 | 47 | |
1994 | Heterogeneity of nucleotide receptors in NG108-15 neuroblastoma and C6 glioma cells for mediating phosphoinositide turnover | WAN-WAN LIN | Journal of Neurochemistry | | | |
2002 | Increased cardiomyocyte apoptosis following ischemia and reperfusion in diet-induced hypercholesterolemia: Relation to Bcl-2 and Bax proteins and caspase-3 activity | WAN-WAN LIN | Lipids | | | |
1999 | Induction of cyclo-oxygenase-2 expression by methyl arachidonyl fluorophosphonate in murine J774 macrophages: Roles of protein kinase C, ERKs and p38 MAPK | WAN-WAN LIN | British Journal of Pharmacology | | | |
1996 | Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages | WAN-WAN LIN | British Journal of Pharmacology | | | |
2003 | Inhibition of IFN-γ-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor γ agonist, 15-deoxy-δ12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway | WAN-WAN LIN | Journal of Immunology | | | |
1992 | Intestinal relaxation by endothelin isopeptides: involvement of Ca2+-activated K+ channels | WAN-WAN LIN | European Journal of Pharmacology | | | |
2001 | Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages | WAN-WAN LIN | Journal of Leukocyte Biology | | | |
1989 | Is direct cardiotoxicity the primary cause of death following i.v. injection of the basic phospholipase A2 from Naja nigricollis venom? | WAN-WAN LIN | Acta Physiologica et Pharmacologica Latinoamericana | | | |
1998 | Lipoxygenase metabolites as mediators of UTP-induced intracellular acidification in mouse RAW 264.7 macrophages | WAN-WAN LIN | Molecular Pharmacology | | | |
1990 | Maitotoxin induces phosphoinositide turnover and modulates glutamatergic and muscarinic cholinergic receptor function in cultured cerebellar neurons | WAN-WAN LIN | Journal of Neurochemistry | | | |
2001 | Modulation of protein kinase A activation by fibronectin matrix proteins at developing neuromuscular synapses in Xenopus laevis cell cultures | WAN-WAN LIN | Molecular Pharmacology | | | |
1992 | Pharmacological characterization of endothelin-stimulated phosphoinositide breakdown and cytosolic free Ca2+ rise in rat C6 glioma cells | WAN-WAN LIN | Journal of Neuroscience | | | |
1985 | Pharmacological study on angusticeps-type toxins from mamba snake venoms | WAN-WAN LIN | Journal of Pharmacology and Experimental Therapeutics | | | |
1987 | Pharmacological study on phospholipases A2 isolated from Naja mossambica mossambica venom. | WAN-WAN LIN | Proceedings of the National Science Council, Republic of China. Part B, Life sciences | | | |